HCK and B-cell chronic lymphocytic leukemia: HCK is overexpressed in Waldenstrom macroglobulinemia (WM) and other hematological malignancies and is targeted by Ibrutinib for the induction of apoptosis in chronic lymphocytic leukemia [37, 38].